Daily News Analysis

Research linked Incentive scheme

stylish_lining

Research linked Incentive scheme

Why in the News?

The Ministry of Science and Technology has written to the Finance Ministry to introduce a Research Linked Incentive (RLI) scheme for the Pharma sector in the upcoming budget of 2024-25.

What is Research linked Incentive scheme?

  1. The RLI scheme has been envisaged on the lines of production-linked incentive (PLI) scheme, to give stimulus to research and development in the field of Science and Technology (S&T).
  2.  The incentives provided to the companies shall total an outlay of Rs. 100 Crore per year, with incremental annual spending in the forthcoming years.
  3. RLI also incorporates policy interventions to harness India’s inherent potential.
  4. The scheme shall operate in addition to the existing incentive R&D schemes available for the Pharma and biotech companies operating in India.

Possible benefits of the scheme:

  1. The incentives provided by the scheme shall enable firm push to Research and development to boost Innovation, that can help to improve India’s ranking in the Global innovation Index (GII) further.

 

 

 

 

  1. Promotes innovation in emerging fields of S&T:
    1. Electric vehicles (EV)
    2. Hydrogen and renewable energy
    3. Sustainable technologies
    4. Artificial intelligence (AI) based smart technologies involving Machine Learning
    5. Semiconductor designing and manufacturing.
  2. Research-linked incentives given sector-specific enables development of sustainable and green technologies in the future.
  3. The scheme shall enable India to shift away from a low-value, high-volume player to a high-value, high-volume player in the global pharma market.

About:

Research & Development in the Pharma sector:

  1. The Pharma R&D processes involves:
    1. Pre-clinical research
    2. Discovery of innovative drugs
    3. Clinical trials of prescription drugs
    4. Preparation and submission of applications for Food and Drug Administration or FDA approval
    5. Designing production processes for the new product
    6. Clinical testing of a new drug against an existing drug to showcase the benefits of the new drug.
    7. Additional clinical trials after a new drug reaches the market
      1. for safety monitoring
      2. Detection of additional side effects that may not have been observed in earlier trials during development
    8. Improvements over existing prescription drugs by developing new dosages and delivery systems and testing for additional potential uses
  2. India’s R&D in Pharma sector:
    1. The gestation period for translation of concept to market may take about 10-15 years, with a >90% attrition rate in the Indian pharma industry.
    2. The need for a early innovation and a cushion for handling the risk of capital needs given the high failure rate stresses the importance of incentives in R&D sector in India.
    3. The average pharma industry funding continues to be around 10%, compared to 15-20% for most large innovators globally. 
    4. Though government grants are provided especially from BIRAC (e.g., the Biotechnology Ignition Grant) and MeiTY, which accounts for about Rs 5-50 lakhs over 6-18 months, it remains largely insufficient for the entire development cycle of drugs.
    5. The R&D Expenditure of India stands at 0.8% of the GDP, way lower than the developed and emerging economies of the world.

 

 
 


UNESCO: R&D intensity as a percentage of GDP (2018)

 

 

 

Indian Ports Act, 2025

Why is the Indian Ports Act, 2025 in the News? The President of India has granted assent to the Indian Ports Act, 2025, which replaces the previous Indian Ports Act of 1908. This new Act aims t
Share It

Private Sector in Defense Production

The growth in private sector participation in India's defense production marks a significant shift in the country’s defense strategy and industrial landscape. The private sector share in
Share It

India-Mauritius

The visit of the Prime Minister of Mauritius to Varanasi marked a significant milestone in strengthening the India-Mauritius bilateral ties. Describing India as a trusted partner in Mauritius'
Share It

solar manufacturing ecosystem

India's ambitious plan to develop a fully indigenous solar manufacturing ecosystem by 2028 is an essential step towards achieving energy security, sustainability, and enhancing its position as
Share It

Political Unrest in Nepal

Nepal’s ongoing political unrest, exacerbated by Prime Minister K P Sharma Oli’s resignation and youth-led protests, has created a volatile environment that directly impacts India&rsqu
Share It

Karnataka Platform-Based Gig Workers

Karnataka has recently passed the Karnataka Platform-Based Gig Workers (Social Security and Welfare) Bill, 2025, aimed at safeguarding the rights and welfare of gig workers. Key Provisions of t
Share It

Income Tax Act 2025

The Income Tax Act, 2025 has received Presidential assent and will replace the Income Tax Act, 1961. The new Act is designed to simplify tax laws, modernize existing provisions, and improve the ef
Share It

Cotton Sector

The Union Government has taken significant steps to support the cotton sector in India, addressing key challenges related to rising imports, farmer welfare, and low domestic production. These meas
Share It

Aircraft Leasing: Wet and Dry Lease

In light of the ongoing global aircraft shortage exacerbated by the COVID-19 pandemic and supply chain disruptions, airlines have increasingly turned to wet and dry leases as solutions. These leas
Share It

India and Israel Sign New Bilateral Investment Treaty (BIT)

India and Israel have recently signed a Bilateral Investment Treaty (BIT), marking a significant development in their bilateral relationship. This agreement, which replaces the older BIT signed in
Share It

Newsletter Subscription


ACQ IAS
ACQ IAS